Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 1/2021

01-07-2021 | Care | Original Paper

Correlates of Engagement in HIV Care Among Transgender Women of Color in the United States of America

Authors: Jae M. Sevelius, Jessica Xavier, Deepalika Chakravarty, JoAnne Keatley, Starley Shade, Greg Rebchook, The SPNS Transgender Women of Color Study Group

Published in: AIDS and Behavior | Special Issue 1/2021

Login to get access

Abstract

HIV prevalence among transgender women of color (TWC) in the United States of America is high. We enrolled TWC living with HIV (N = 858) to evaluate 1nine HIV care interventions. We examined factors associated with four outcomes at enrollment: linkage to care, ever being on antiretroviral treatment, retention in care and viral suppression. The sample was 49% Hispanic/Latino, 42% Black; average age was 37 years; 77% were ever linked to care, 36% were ever on treatment, 22% were retained in care, and 36% were virally suppressed. Current hormone use was significantly associated with linkage, retention, and viral suppression (all aORs > 1.5), providing evidence for gender-affirming care as an important facilitator of engagement in HIV care. Greater health care empowerment was significantly associated with greater odds of all outcomes (aORs between 1.19 and 1.37). These findings identify potential intervention targets to improve the provision of care and treatment for TWC living with HIV.
Literature
1.
Meerwijk EL, Sevelius JM. Transgender population size in the United States: a meta-regression of population-based probability samples. Am J Public Health. 2017;107(2):e1–8.CrossRef
2.
Streed CG Jr, McCarthy EP, Haas JS. Self-reported physical and mental health of gender nonconforming transgender adults in the United States. LGBT Health. 2018;5(7):443–8.CrossRef
3.
Conron KJ, Scott G, Stowell GS, Landers SJ. Transgender health in Massachusetts: results from a household probability sample of adults. Am J Public Health. 2011;102(1):118–22.CrossRef
4.
Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22.CrossRef
5.
6.
7.
James SE, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M. The Report of the 2015 U.S. transgender survey. Washington, DC: National Center for Transgender Equality; 2016.
8.
Bradford J, Reisner SL, Honnold JA, Xavier J. Experiences of transgender-related discrimination and implications for health: results from the Virginia transgender health initiative study. Am J Public Health. 2013;103(10):1820–9.CrossRef
9.
Kattari SK, Walls NE, Whitfield DL, Langenderfer-Magruder L. Racial and ethnic differences in experiences of discrimination in accessing health services among transgender people in the United States. Int J Transgenderism. 2015;16(2):68–79.CrossRef
10.
Lacombe-Duncan A. An intersectional perspective on access to HIV-related healthcare for transgender women. Transgender health. 2016;1(1):137–41.CrossRef
11.
Dolan IJ, Strauss P, Winter S, Lin A. Misgendering and experiences of stigma in health care settings for transgender people. Med J Aust. 2020;212(4):150-1.e1.CrossRef
12.
White Hughto JM, Reisner SL, Pachankis JE. Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015;147:222–31.CrossRef
13.
Valentine SE, Shipherd JC. A systematic review of social stress and mental health among transgender and gender non-conforming people in the United States. Clin Psychol Rev. 2018;66:24–38.CrossRef
14.
Amin P, Douaihy A. Substance use disorders in people living with human immunodeficiency virus/AIDS. Nurs Clin North Am. 2018;53(1):57–65.CrossRef
15.
Cama E, Brener L, Slavin S, de Wit J. The relationship between negative responses to HIV status disclosure and psychosocial outcomes among people living with HIV. J Health Psychol. 2017;25(4):538–44.CrossRef
16.
Smith R, Rossetto K, Peterson BL. A meta-analysis of disclosure of one’s HIV-positive status, stigma and social support. AIDS Care. 2008;20(10):1266–75.CrossRef
17.
Modi RA, McGwin GL, Willig JH, Westfall AO, Griffin RL, Amico R, et al. Factors associated with HIV disclosure status among iENGAGE cohort of new to HIV care patients. AIDS Patient Care STDS. 2020;34(5):213–27.CrossRef
18.
Sevelius J. Gender affirmation: a framework for conceptualizing risk behavior among transgender women of color. Sex Roles. 2013;68(11–12):675–89.CrossRef
19.
Sevelius J, Chakravarty D, Neilands TB, Keatley J, Shade SB, Johnson MO, et al. Evidence for the Model of Gender Affirmation: The Role of Gender Affirmation and Healthcare Empowerment in Viral Suppression Among Transgender Women of Color Living with HIV. AIDS Behav. 2019;29:1–8.
20.
Johnson MO. The shifting landscape of health care: toward a model of health care empowerment. Am J Public Health. 2011;101(2):265–70.CrossRef
21.
Wilson E, Chen Y-H, Arayasirikul S, Wenzel C, Raymond HF. Connecting the dots: examining transgender women’s utilization of transition-related medical care and associations with mental health, substance use, and HIV. J Urban Health. 2015;92(1):182–92.CrossRef
22.
Gorin-Lazard A, Baumstarck K, Boyer L, Maquigneau A, Gebleux S, Penochet J-C, et al. Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study. J Sex Med. 2012;9(2):531–41.CrossRef
23.
Rebchook G, Keatley J, Contreras R, Perloff J, Molano LF, Reback CJ, et al. The transgender women of color initiative: implementing and evaluating innovative interventions to enhance engagement and retention in HIV Care. Am J Public Health. 2017;107(2):224–9.CrossRef
24.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.CrossRef
25.
U.S. Department of Health and Human Services. 2013 Poverty guidelines. Assistant secretary for planning and evaluation, HHS; 2013.
26.
Johnson MO, Rose CD, Dilworth SE, Neilands TB. Advances in the conceptualization and measurement of health care empowerment: development and validation of the health care empowerment inventory. PLoS ONE. 2012;7(9):e45692.CrossRef
27.
Jefferson K, Neilands T, Sevelius J. Transgender women of color: discrimination and depression symptoms. Ethn Inequal Health Soc Care. 2014;6(4):121–36.CrossRef
28.
Landrine H, Klonoff E. The schedule of racist events: a measure of racial discrimination and a study of its negative physical and mental health consequences. J Black Psychol. 1996;22:144–68.CrossRef
29.
Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J. Two shorter forms of the CES-D depression symptoms index. J Aging Health. 1993;5(2):179–93.CrossRef
30.
Zhang W, O’Brien N, Forrest JI, Salters KA, Patterson TL, Montaner JSG, et al. Validating a shortened depression scale (10 Item CES-D) among HIV-positive people in British Columbia, Canada. PLOS ONE. 2012;7(7):e40793.CrossRef
31.
Andresen E, Malmgren J, Carter W, Patrick D. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10:77–84.CrossRef
32.
33.
Muthén LK, Muthén BO. MPlus Software. Los Angeles, CA: Muthén & Muthén; 1998–2020.
34.
Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006–2017. Am J Public Health. 2019;109(1):e1–8.CrossRef
35.
36.
Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDS. 2014;28(3):128–35.CrossRef
37.
Jin H, Restar A, Biello K, Kuhns L, Reisner S, Garofalo R, et al. Burden of HIV among young transgender women: factors associated with HIV infection and HIV treatment engagement. AIDS Care. 2019;31(1):125–30.CrossRef
38.
Porter K, Brennan-Ing M. The intersection of transgender identities, HIV, and aging. In: Hardacker C, Ducheny K, Houlberg M, editors. Transgender and gender nonconforming health and aging. Switzerland: Springer; 2019. p. 61–77.CrossRef
39.
40.
Poteat T, Wirtz AL, Reisner S. Strategies for engaging transgender populations in HIV prevention and care. Curr Opin HIV AIDS. 2019;14(5):393–400.CrossRef
41.
Rosen JG, Malik M, Cooney EE, Wirtz AL, Yamanis T, Lujan M, et al. Antiretroviral treatment interruptions among Black and Latina transgender women living with HIV: characterizing co-occurring, multilevel factors using the gender affirmation framework. AIDS Behav. 2019;23(9):2588–99.CrossRef
42.
Operario D, Nemoto T. HIV in transgender communities: syndemic dynamics and a need for multicomponent interventions. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S91–3.CrossRef
43.
Wilson TE, Kay ES, Turan B, Johnson MO, Kempf M-C, Turan JM, et al. Healthcare empowerment and HIV viral control: mediating roles of adherence and retention in care. Am J Prev Med. 2018;54(6):756–64.CrossRef
44.
45.
46.
Reback CJ, Ferlito D, Kisler KA, Fletcher JB. Recruiting, linking, and retaining high-risk transgender women into HIV prevention and care services: an overview of barriers, strategies, and lessons learned. Int J Transgenderism. 2015;16(4):209–21.CrossRef
47.
Poteat T, German D, Flynn C. The conflation of gender and sex: gaps and opportunities in HIV data among transgender women and MSM. Glob Public Health. 2016;11(7–8):835–48.CrossRef
48.
Kaplan RL, Sevelius J, Ribeiro K. In the name of brevity: the problem with binary HIV risk categories. Glob Public Health. 2016;11(7–8):824–34.CrossRef
49.
Aggleton P, Parker R. Moving beyond biomedicalization in the HIV response: implications for community involvement and community leadership among men who have sex with men and transgender people. Am J Public Health. 2015;105(8):1552–8.CrossRef
Metadata
Title
Correlates of Engagement in HIV Care Among Transgender Women of Color in the United States of America
Authors
Jae M. Sevelius
Jessica Xavier
Deepalika Chakravarty
JoAnne Keatley
Starley Shade
Greg Rebchook
The SPNS Transgender Women of Color Study Group
Publication date
01-07-2021
Publisher
Springer US
Published in
AIDS and Behavior / Issue Special Issue 1/2021
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-021-03306-9

Other articles of this Special Issue 1/2021

AIDS and Behavior 1/2021 Go to the issue

OriginalPaper

A Latent Class Analysis of Chronic Health Conditions Among HIV-Positive Transgender Women of Color

Original Paper

“She is Like a Sister to Me.” Gender-Affirming Services and Relationships are Key to the Implementation of HIV Care Engagement Interventions with Transgender Women of Color

OriginalPaper

Violence Inflicted on Latina Transgender Women Living with HIV: Rates and Associated Factors by Perpetrator Type

Original Paper

Evaluation of Translife Care: An Intervention to Address Social Determinants of Engagement in HIV Care Among Transgender Women of Color

Original Paper

Drug Use is Associated with Delayed Advancement Along the HIV Care Continuum Among Transgender Women of Color

Original Paper

Young Transgender Women of Color: Homelessness, Poverty, Childhood Sexual Abuse and Implications for HIV Care
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits